Moberg Pharma (Sweden)
Moberg Pharma AB (publ) is a Swedish pharmaceutical company focused on commercializing proprietary innovations based on drug delivery of proven compounds. The company’s drug MOB-015 is a novel topical treatment for onychomycosis (nail fungus) with market approval in 13 EU countries. MOB-015 is sold in Sweden under...
Basic Information
- Category: business
- Website: http://mobergpharma.com/
Documented Facts
- Inception (Wikidata): 2006 (Source 3: Wikidata Q10587142, revision 2474421169)
- Legal form (Wikidata; date unspecified): aktiebolag (Source 3: Wikidata Q10587142, revision 2474421169; Source 4: Wikidata label: Q422007, revision 2486113600)
- Country (Wikidata; date unspecified): Sweden (Source 3: Wikidata Q10587142, revision 2474421169; Source 5: Wikidata label: Q34, revision 2547805093)
- Official website (Wikidata; date unspecified): http://mobergpharma.com/ (Source 3: Wikidata Q10587142, revision 2474421169)
Evidence and Sources
- Moberg Pharma (Sweden) — Official Site (official)
- Moberg Pharma (Sweden) on linkedin (social)
- Wikidata Q10587142, revision 2474421169 (knowledge-base)
- Wikidata label: Q422007, revision 2486113600 (knowledge-base)
- Wikidata label: Q34, revision 2547805093 (knowledge-base)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Moberg Pharma (Sweden).
- Canonical profile: https://brandsource.ai/brands/moberg-pharma-sweden
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/moberg-pharma-sweden/json-ld
- Citation profile API: https://brandsource.ai/api/brands/moberg-pharma-sweden/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (94/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-21
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Moberg Pharma AB (publ) is a Swedish pharmaceutical company focused on commercializing proprietary innovations based on drug delivery of proven compounds. The company’s drug MOB-015 is a novel topical treatment for onychomycosis (nail fungus) with market approval in 13 EU countries. MOB-015 is sold in Sweden under...
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 4 supporting sources linked.
- 4 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.